DMARDs Day 2024
Le 22 mai dernier, s’est tenu, à Lille, le 11e DMARDs Day organisé par le Laboratoire Nordic Pharma. Après la plénière animée par le président de l’édition 2024, le Pr…
Site professionnel spécialisé en Rhumatologie
Le 22 mai dernier, s’est tenu, à Lille, le 11e DMARDs Day organisé par le Laboratoire Nordic Pharma. Après la plénière animée par le président de l’édition 2024, le Pr…
OP0025. Rahman P, Mease PJ, Deodhar A et al. Factors associated with fatigue and its improvement – a principal component analysis of patients with active psoriatic arthritis from guselkumab phase…
OP0028. Snoeck Henkemans S, De Jong P, Luime J et al. Early achievement of minimal disease activity in psoriatic arthritis is associated with long-term improvements in quality of life. Eular…
OP0257. Cordtz R, Askling J, Delcoigne B et al. Risk of haematological malignancy in patients with psoriatic arthritis, overall and in relation to TNF inhibitors - a Nordic cohort study.…
OP0255. Merola JF, McInnes I, Ritchlin CT et al. Bimekizumab in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: 16-week efficacy & safety from…
OP0261. Michielsens C, den Broeder N, van den Hoogen F et al. Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomized controlled…
OP0249. Machado PM, Schaefer M, Mahil S et al. Characteristics associated with poor Covid-19 outcomes in people with psoriasis and spondyloarthritis: data from the Covid-19 PsoProtect and global rheumatology alliance…
Ogdie A, Blachley T, Emeanuru K et al. Characteristics of Patients with Early Oligoarticular Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. Abstract Number: 0306.</a
Philip Mease, Arthur Kavanaugh, Dafna Gladman et al. Characterization of Remission in Patients with Psoriatic Arthritis Treated with Upadacitinib: Post-hoc Analysis from Two Phase 3 Trials.ABSTRACT NUMBER: 1355.
Baptiste Coste, Charlotte Traverson, Elisabeth Filhol et al. Catastrophizing in Patients with Axial Spondyloarthritis and Psoriatic Arthritis. Abstract Number: 1318.
Résumé La stratégie du Treat-to-target (T2T) préconise un suivi rapproché utilisant des outils standardisés, avec pour objectif d’atteindre une cible prédéfinie de rémission ou de faible activité de la maladie.…
